Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience
Authors:
- Els NijsENEls Nijs
- Deddeh BallahDBDeddeh Ballah
- Deborah RabinowitzDRDeborah Rabinowitz
- Lynn ThompsonLTLynn Thompson
- Natalie RintoulNRNatalie Rintoul
- Holly HedrickHHHolly Hedrick
- Ian JacobsIJIan Jacobs
- David LowDLDavid Low
- 1 November 2011
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (11) , 2083-2095
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Current concepts in the classification, diagnosis and treatment of vascular anomaliesEuropean Journal of Radiology, 2010
- Treatment of Lymphatic Malformations With OK-432 (Picibanil)Journal of Craniofacial Surgery, 2009
- Efficacy and safety of OK‐432 immunotherapy of lymphatic malformationsThe Laryngoscope, 2008
- Percutaneous Sclerotherapy of Lymphatic Malformations with DoxycyclineLymphatic Research and Biology, 2008
- Definitive percutaneous treatment of lymphatic malformations of the trunk and extremitiesJournal of Pediatric Surgery, 2008
- Absence of Tooth Staining With Doxycycline Treatment in Young ChildrenClinical Pediatrics, 2007
- Current Concepts in Lymphatic MalformationVascular and Endovascular Surgery, 2005
- OK-432 therapy in 64 patients with lymphangiomaJournal of Pediatric Surgery, 1994
- Hemolytic Anemia after Tetracycline TherapyNew England Journal of Medicine, 1985
- Tetracycline-induced hemolytic anemiaJournal of the American Academy of Dermatology, 1980